Dr. Falk Pharma GmbH | Finanzwire

Basculer en Français

10100	Companies
206816	Keywords
136955	Articles
109608	Press releases

Home
Companies
Dr. Falk Pharma GmbH

BRIEF

published on 10/29/2024 at 13:05, 1 year 4 months ago

Dr. Falk Pharma Acquires Kynos Therapeutics, Enhancing Portfolio in Inflammatory Diseases

Inflammatory Diseases Dr. Falk Pharma Kynos Therapeutics Acute Pancreatitis KNS366
PRESS RELEASE

published on 10/29/2024 at 13:00, 1 year 4 months ago

Dr. Falk Pharma Acquires Kynos Therapeutics, Adding Acute Pancreatitis as a Therapeutic Focus and Further Strengthening Its Development Portfolio
Dr. Falk Pharma GmbH acquires Kynos Therapeutics Ltd., focusing on inflammatory disease treatments. KNS366, a novel enzyme inhibitor, shows promise in clinical trials for acute pancreatitis

Inflammatory Diseases Dr. Falk Pharma Kynos Therapeutics Acute Pancreatitis KNS366

Accesswire

Published on 03/26/2026 at 16:20, 1 hour 46 minutes ago

ACCESS Newswire Upgrades the ACCESS Platform to Include Social Monitoring to Track Brand Conversations Across Major Social Platforms
Published on 03/26/2026 at 14:05, 4 hours 1 minute ago

SouthGobi Announces Profit Warning
Published on 03/26/2026 at 13:00, 5 hours 6 minutes ago

Prospect Ridge Strengthens Technical Team with Appointment of Phil Smerchanski as Senior Technical Advisor
Published on 03/26/2026 at 13:00, 5 hours 6 minutes ago

GameSquare's Stream Hatchet Launches Creator Communities to Manage the Full Creator Marketing Lifecycle
Published on 03/26/2026 at 12:59, 5 hours 7 minutes ago

Adcore Concludes Fiscal Year 2025 With Strong Q4 Performance

View all ACCESSWIRE

EQS Group

Published on 03/26/2026 at 17:51, 15 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 03/26/2026 at 17:45, 21 minutes ago

CTS EVENTIM exceeds EUR 3 billion in revenue for the first time, sustaining profitable growth
Published on 03/26/2026 at 17:20, 45 minutes ago

EQS-Adhoc: Leifheit Aktiengesellschaft: Board of Management and Supervisory Board propose to the Annual General Meeting a capital increase from the company’s own funds, followed by an ordinary capital reduction
Published on 03/26/2026 at 17:19, 47 minutes ago

Haier Smart Home Reports Full-Year 2025 Results: Global Revenue Surpasses RMB 300 Billion for the First Time; Net Profit Reaches a Record Highs
Published on 03/26/2026 at 17:13, 52 minutes ago

Custodian Property Income REIT plc: Share Buyback

Les Echos

Published on 03/26/2026 at 17:45, 21 minutes ago

Cegedim: profitability continues to improve
Published on 03/26/2026 at 08:57, 9 hours 8 minutes ago

Edenred statement
Published on 03/26/2026 at 07:30, 10 hours 36 minutes ago

BIOPHYTIS-LYNXKITE ALLIANCE INVITED TO NVIDIA CONFERENCE: UNLEASHING AI TO REVOLUTIONIZE LONGEVITY
Published on 03/25/2026 at 18:53, 23 hours 13 minutes ago

LNA SANTE : 2025 Annual Results
Published on 03/25/2026 at 18:31, 23 hours 35 minutes ago

Strong investment performance and active roll-out of our strategy

View all LES ECHOS COMFI WIRE